1. Background and Introduction Trioday, produced by Cipla Ltd., represents a fixed-dose combination (FDC) antiretroviral medicine employed for managing Human Immunodeficiency Virus (HIV) infection. As a complete single-tablet regimen taken once daily, it marks a notable step forward in HIV care by merging three active pharmaceutical ingredients into a single https://hivhub.in/product/trioday-tablet/